Real-world acne treatment adherence spans 6% to 84%, with cost, adverse effects, and slow results driving nonadherence.
A value-based care pilot within Kentucky’s Medicaid program reduced total costs for adults with substance use disorder while ...
Senator Andy Kim (D, New Jersey) discusses the response to a Senate speech on caregiving and disagreements over how to ...
High efficacy has no single definition, and a large toolbox means little when formularies limit access. The panel describes ...
Pimicotinib, a once-daily oral CSF-1R inhibitor, is now FDA approved for adults with TGCT for whom surgery may worsen ...
Florin Draica, MD, MBA, of Shionogi outlines how clinicians and pharmacies can expand access to ensitrelvir postexposure ...
Pooled real-world data show an 88% response rate with brexu-cel in relapsed mantle cell lymphoma (MCL), but cost and QOL data ...
Employer diabetes guide; Camden psychedelic therapy input; CRC after EMR; rural HFrEF care; JAMA obesity report.
In a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated ...
Faculty say heart failure patients miss iron deficiency care when no one owns it; pharmacist-led workflows may help close the ...
Obinutuzumab (Gazyva) led to complete remission of proteinuria in more patients than tacrolimus did, according to the FDA.
Pharmacy teams can shorten the time of Medicare GLP-1 Bridge approvals, but 2027 approval windows may leave patients without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results